INTRODUCTIONRetroperitoneal sarcoma accounts for 15% of all sarcomas and liposarcoma represents approximately 50% of these rare malignancies. Complete surgical resection remains the most effective therapeutic modality. Despite optimal extirpation of the tumor, local recurrence of retroperitoneal sarcoma (RPLPS) is a common clinical problem and is the most common cause of mortality, with up to 70% of deaths occurring in the absence of distant metastasis.An on‐going problem following resection of the first local recurrence is the management of multiple recurrences. Multiply locally recurrent RPLPS can occur in up to 69–80% of first recurrent cases and constitutes a challenging management problem for a sarcoma team. The extent and optimal timing of resection and role of systemic and radiation therapy are not entirely clear. Therefore, there is a critical need to understand the natural history and current management of multiply recurrent RPLPS. This review article will summarize predictors of recurrent (first and multiple) RPLPS and will highlight the important concepts in the management of these difficult to treat tumors.FACTORS INFLUENCING RATES AND PATTERN OF FAILUREThe factors that influence the rates and pattern of failure of all RPS histologic subtypes can be attributed to patient characteristics, tumor features, and surgical variables; however, few
Journal of Surgical Oncology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera